2022 HFCT Focused Update of the 2019 HFCT Heart Failure Guidelines: Part 1 - Heart Failure Classification and Pharmacological Treatment for Heart Failure with Reduced Ejection Fraction (HFrEF)
Aekarach Ariyachaipanich¹, Adisai Buakhamsri², Arintaya Phrommintikul³, Srisakul Chirakarnjanakorn⁴, Rungroj Krittayaphong⁴, Vichai Senthong⁵, Bundit Naratreekoon⁶, Teerapat Yingchoncharoen⁶
Affiliation : ¹ Division of Cardiovascular Medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, ² Cardiology Department, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand, ³ Cardiovascular Unit, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, ⁴ Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, ⁵ Cardiovascular Unit, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand, ⁶ Cardiology Unit, Department of Internal Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Received 27 June 2022 | Revised 17 August 2022 | Accepted 1 September 2022
DOI: 10.35755/jmedassocthai.2022.11.13702
Keywords :
